The sos news, uighur net blood (603014) responded to investors ' concerns on the investor relations platform on 02/07。
Investors: please ask 1. Why did the company choose indonesia as an overseas deployment country, and for what specific reasons? 2. The use of peritoneal dialysis is low in the country, and what are the advantages of this business and how much management can do over the next three years? 3. What are companies thinking about endogenous and extended development paths? Thank you
Wilhelm: good investor, thank you for your interest in the company! In indonesia, with its large population, the blood purification industry has great prospects for development and is in line with the company's overseas deployment development strategy; the company's neutral, low-GDP double-portal peritoneal dialysis is the country's first approved and marketed neutral peritoneal dialysis product with clear product advantages. At the same time, companies will rely on the advantages of r & d, channels, etc., to continuously improve the quality of their products and expand their markets; they will continue to achieve endogenous growth through technological r & d and organizational efficiency, while also actively seeking external cooperation and resource integration to achieve high-quality corporate development, consistent with relevant laws and regulations。
Investors: in the field of perimenal dialysis, are there products for firm enhanced dialysis (for diabetes kidney disease), low GDP (glucose degradation product) dialysis, amino acid perimenary dialysis, etc.? What's the layout of the company
Wilhelm: good investor, thank you for your interest in the company! The company currently has two major series of perimenal dialysis (single-port) and perimenal dialysis (twice-pack) products of dozens of different types. Among them, the neutral, low-GDP double-portal peritoneal dialysis is the first marketed neutral peritoneal dialysis product in the country. In 2024, company peritoneal dialysis accounted for 6. 77 per cent of the main operating income。
Investors: wigand has established four major regional marketing centres worldwide, six overseas research and development centres and 15 overseas offices. What is the immediate significance for listed companies in terms of uber blood
Wilhelm: good investor, thank you for your interest in the company! As the controlling shareholders of the company, the group will actively empower the company to operate and help it to develop overseas markets, subject to the conditions of compliance with relevant laws and regulations。
The above elements, which are publicly available information, are generated by ai algorithms (cylindrical code 310104345710301240019) and do not constitute an investment proposal。
